AllianceBernstein’s KalVista Pharmaceuticals KALV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $452K | Hold |
40,020
| – | – | ﹤0.01% | 2702 |
|
|
2025
Q1 | $462K | Hold |
40,020
| – | – | ﹤0.01% | 2588 |
|
|
2024
Q4 | $339K | Hold |
40,020
| – | – | ﹤0.01% | 2810 |
|
|
2024
Q3 | $463K | Sell |
40,020
-2,430
| -6% | -$28.1K | ﹤0.01% | 2692 |
|
|
2024
Q2 | $500K | Buy |
42,450
+12,440
| +41% | +$147K | ﹤0.01% | 2667 |
|
|
2024
Q1 | $356K | Hold |
30,010
| – | – | ﹤0.01% | 2740 |
|
|
2023
Q4 | $368K | Sell |
30,010
-2,400
| -7% | -$29.4K | ﹤0.01% | 2758 |
|
|
2023
Q3 | $312K | Hold |
32,410
| – | – | ﹤0.01% | 2782 |
|
|
2023
Q2 | $292K | Buy |
32,410
+6,710
| +26% | +$60.4K | ﹤0.01% | 2872 |
|
|
2023
Q1 | $202K | Hold |
25,700
| – | – | ﹤0.01% | 2903 |
|
|
2022
Q4 | $174K | Buy |
25,700
+8,636
| +51% | +$58.4K | ﹤0.01% | 3034 |
|
|
2022
Q3 | $248K | Buy |
17,064
+1,964
| +13% | +$28.5K | ﹤0.01% | 2939 |
|
|
2022
Q2 | $149K | Buy |
15,100
+4,700
| +45% | +$46.4K | ﹤0.01% | 3070 |
|
|
2022
Q1 | $153K | Sell |
10,400
-1,800
| -15% | -$26.5K | ﹤0.01% | 3039 |
|
|
2021
Q4 | $161K | Hold |
12,200
| – | – | ﹤0.01% | 3117 |
|
|
2021
Q3 | $213K | Hold |
12,200
| – | – | ﹤0.01% | 3060 |
|
|
2021
Q2 | $292K | Buy |
+12,200
| New | +$292K | ﹤0.01% | 3006 |
|
|
2021
Q1 | – | Sell |
-18,800
| Closed | -$357K | – | 3253 |
|
|
2020
Q4 | $357K | Sell |
18,800
-900
| -5% | -$17.1K | ﹤0.01% | 2759 |
|
|
2020
Q3 | $248K | Hold |
19,700
| – | – | ﹤0.01% | 2885 |
|
|
2020
Q2 | $238K | Buy |
19,700
+7,400
| +60% | +$89.4K | ﹤0.01% | 2947 |
|
|
2020
Q1 | $94K | Buy |
12,300
+2,200
| +22% | +$16.8K | ﹤0.01% | 2963 |
|
|
2019
Q4 | $180K | Hold |
10,100
| – | – | ﹤0.01% | 2936 |
|
|
2019
Q3 | $117K | Buy |
+10,100
| New | +$117K | ﹤0.01% | 3040 |
|